Items 1 to 10 of 46 total
per page
Page:
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

May 2017 Antibody UpdateMay 2017: The Antibody Update

In the May Antibody Update, you can expect to find news of an enzyme inhibitor that increases the efficacy of anti-PD-1 Immunotherapy, the generation of induced pluripotent blood stem cells, and the rapid employment of the latest Ebola vaccine in the Democratic Republic of the Congo. Learn more at ProSci.

Read More
Monday, June 5, 2017 3:37:34 PM America/Los_Angeles
Posted in News By Jonathan Felix

Why are antibodies produced in the body?

Why are antibodies produced in the body?

Antibodies are produced in the body to serve 3 major purposes in the immune system: neutralization, opsonization, and compliment protein activation. Each of these functions helps to protect the body from potentially harmful pathogens. Learn more at ProSci Inc.



Read More
Friday, May 26, 2017 1:56:18 PM America/Los_Angeles
Posted in Science Corner By Jonathan Felix

April 2017 Antibody UpdateApril 2017: The Antibody Update

In the April 2017 Antibody Update, ProSci presents to you a virucidal peptide found in the skin of frogs, evidence of new and hopeful RNA-drugs, and the innate immune systems role in congenital autoimmunity. 


Read More
Friday, May 5, 2017 12:17:25 PM America/Los_Angeles
Posted in News By Yousif Slaiwa

Antibody Basics: Selecting AntigensAntibody Basics: Selecting Antigens

Selecting the proper antigen is paramount for assuring  the development of desired antibodies; however, the proper antigen must still maintain immunoreacivity in order to develop antibodies. This dilemma can be solved for for several antigens. In this blog we discuss targeting glycosylated proteins and highly conserved mammalian proteins for antibody development.

Read More
Monday, May 1, 2017 10:19:33 AM America/Los_Angeles
Posted in Science Corner By Jonathan Felix

March 2017 Antibody UpdateMarch 2017: The Antibody Update

This month the Antibody Update showcases caffeine as a potential anti-inflammatory agent, how mTOR is related to granuloma formation, and a retinal transplant using induced pluripotent stem cells. Learn more here!


Read More
Friday, March 31, 2017 10:00:00 AM America/Los_Angeles
Posted in News By Yousif Slaiwa

February 2017 Antibody UpdateFebruary 2017: The Antibody Update

This month's Antibody Update includes news on how your skin bacteria regulate levels of Staphylococus aureus, a new study using single cell sequence analysis to create 3D models of tumor tissue, and development of chimeric antigen receptor T-cells using CRISPR/Cas9 to enhance immunotherapy.

Read More
Monday, March 6, 2017 12:11:46 PM America/Los_Angeles
Posted in News By Jonathan Felix

ProSci Blog Personalized MedicineProblems with Immunotherapy

Immune system checkpoint inhibition may not always be the perfecct way to target cancer. Why is it that some patients do not respond positively to certain immunotherapy treatments like Ipilimumab? This blog takes into account the immune system's convoluted nature to understand how immune checkpoint antibodies may not be the problem, and how personalized medicine could help.

Read More
Wednesday, February 15, 2017 10:00:00 AM America/Los_Angeles
Posted in Science Corner By Yousif Slaiwa

January 2017 Antibody UpdateJanuary 2017: The Antibody Update

The start of the new year has brought some interesting new stories in science and science policy. This Antibody Update looks at The Reproducibility Project's efforts in cancer drug research, changes to encourage vaccine development against less known, but still threatening viruses, and a new study on the mechanism of how macrophages cross the vascular endothelium.

Read More
Monday, February 6, 2017 9:09:09 AM America/Los_Angeles
Posted in News By Jonathan Felix

T-cell Activation ProSci BlogT-cell Activation: The Purpose of CD28, CTLA-4, and CD80/CD86 

Cancer immunotherapy involves targeting receptors and ligands of T-cells and tumor cells to amplify an immune response. By targeting these receptors and ligands, T-cell anti-cancer activity can be regulated. This blog explains how the receptors CD28 and CTLA-4 and their ligands CD80 and CD86 are involved in T-cell activation and inhibition. Take a look!

Read More
Tuesday, January 17, 2017 10:00:00 AM America/Los_Angeles
Posted in Science Corner By Jonathan Felix

November 2016 Antibody UpdateDecember 2016: The Antibody Update

ProSci's last Antibody Update of 2016 includes the super effective Ebola vaccine developed by Merck, using the common diabetes drug metformin and the antihypertensive syrosingopine to combat cancer, and a link to a highlight review of the immune checkpoint TIGIT. Check it out!

Read More
Tuesday, January 3, 2017 10:00:00 AM America/Los_Angeles
Posted in News By Jonathan Felix
Items 1 to 10 of 46 total
per page
Page:
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5